FTC Should Send Warning Letters For Potentially Misleading Claims – Petition
This article was originally published in The Tan Sheet
The Federal Trade Commission should use warning letters when contested health benefit claims are "at worst, only potentially misleading," according to a petition for rulemaking submitted to FTC April 15
You may also be interested in...
Providing companies with advisory opinions clarifying Federal Trade Commission positions on "competent and reliable scientific evidence" standards for dietary supplement ad claims may not be feasible due to human resource concerns and previous rulings, the commission states.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning